Jaipur, February 8, 2025 – Eris Lifesciences spearheaded a significant event in Jaipur, Sitapura, where 500 dermatologists from across India gathered for a 2-km walkathon. The event, held in collaboration with DERMACON 2025, focused on the critical role of weight management in psoriasis care, advocating for lifestyle changes to enhance treatment outcomes.
Psoriasis is often linked with comorbidities, meaning other health conditions that occur alongside it. One of the most notable associations is with metabolic syndrome, a cluster of conditions that increase the risk of heart disease, stroke, and type 2 diabetes. Studies have shown that metabolic syndrome is significantly more prevalent in people with psoriasis compared to those without the condition and specifically, 39.3% of psoriatic patients have metabolic syndrome.
Weight loss has been scientifically linked to a reduction in psoriasis severity. This is because obesity and psoriasis share common inflammatory pathways, and excess body weight has been shown to exacerbate psoriasis symptoms.
Renowned health icon Milind Soman will be the chief guest, leading the walkathon and advocating for holistic well-being. Speaking about the initiative, Milind Soman stated, “Fitness is the foundation of overall health, and its role in managing chronic conditions like psoriasis cannot be overlooked. A balanced lifestyle that includes regular physical activity and healthy nutrition can significantly improve skin health and overall quality of life. I am thrilled to be part of this initiative that sheds light on this important health aspect.”
Dr V S Joshi, President Medical Service, Derma, Eris Lifesciences, expressed enthusiasm about the event, stating, “We are proud to lead this initiative that not only addresses psoriasis care but also underscores the transformative power of lifestyle modifications. This walkathon symbolizes our commitment to pioneering patient-centric solutions that go beyond traditional medication.”
The walkathon, held under the hashtag #SoarOverPsoriasis, is expected to amplify discussions around psoriasis management and inspire collective efforts toward patient-centric care.
